IMCR

Immunocore (IMCR)

Immunocore Holdings PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IMCR

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/11	05:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMCR	Immunocore Holdings PLC
2025/03/11	04:00	GlobeNewswire Inc.	Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025	NASDAQ:IMCR	Immunocore Holdings PLC
2025/03/03	21:00	GlobeNewswire Inc.	Immunocore to present at upcoming investor conferences	NASDAQ:IMCR	Immunocore Holdings PLC
2025/02/28	06:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2025/02/28	06:29	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2025/02/26	21:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMCR	Immunocore Holdings PLC
2025/02/26	21:00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:IMCR	Immunocore Holdings PLC
2025/02/26	21:00	GlobeNewswire Inc.	Immunocore reports fourth quarter and full year 2024 financial results and provides a business update	NASDAQ:IMCR	Immunocore Holdings PLC
2025/02/20	06:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2025/02/20	06:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2025/02/20	06:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2025/02/20	06:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMCR	Immunocore Holdings PLC
2025/02/19	21:00	GlobeNewswire Inc.	Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025	NASDAQ:IMCR	Immunocore Holdings PLC
2025/01/11	06:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMCR	Immunocore Holdings PLC
2025/01/10	21:00	GlobeNewswire Inc.	Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:IMCR	Immunocore Holdings PLC
2025/01/06	21:00	GlobeNewswire Inc.	Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:IMCR	Immunocore Holdings PLC
2025/01/02	21:33	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMCR	Immunocore Holdings PLC
2025/01/02	21:00	GlobeNewswire Inc.	Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development	NASDAQ:IMCR	Immunocore Holdings PLC
2024/12/23	21:00	GlobeNewswire Inc.	Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME	NASDAQ:IMCR	Immunocore Holdings PLC
2024/12/17	21:00	GlobeNewswire Inc.	Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers	NASDAQ:IMCR	Immunocore Holdings PLC
2024/12/11	21:00	GlobeNewswire Inc.	EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma	NASDAQ:IMCR	Immunocore Holdings PLC
2024/12/03	15:00	GlobeNewswire Inc.	Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma	NASDAQ:IMCR	Immunocore Holdings PLC
2024/11/09	06:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMCR	Immunocore Holdings PLC
2024/11/08	21:00	GlobeNewswire Inc.	Immunocore to present at upcoming investor conferences	NASDAQ:IMCR	Immunocore Holdings PLC
2024/11/06	21:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMCR	Immunocore Holdings PLC
2024/11/06	21:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IMCR	Immunocore Holdings PLC
2024/11/06	21:00	GlobeNewswire Inc.	Immunocore reports third quarter financial results and provides a business update	NASDAQ:IMCR	Immunocore Holdings PLC
2024/09/16	19:46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMCR	Immunocore Holdings PLC
2024/09/14	16:00	GlobeNewswire Inc.	Immunocore presents Phase 1 data of brenetafusp, an ImmTAC bispecific targeting PRAME, in patients with ovarian cancer	NASDAQ:IMCR	Immunocore Holdings PLC
2024/09/13	05:05	GlobeNewswire Inc.	Immunocore to present at the 2024 Cantor Global Healthcare Conference	NASDAQ:IMCR	Immunocore Holdings PLC